MedTrace Logo

Detection of Chromosomal Aberrations in Urine Samples Using Fluorescent in Situ Hybridization (FISH) (UroVysion Test)

NCT01264744 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 174

Last updated 2010-12-23

No results posted yet for this study

Summary

The purpose of the study is the identification of chromosomal aberrations in urine samples.

The imaging system is intended for diagnostic use as an aid to the pathologist in the detection, counting and classification of UroVysion FISH stained Urine samples.

Conditions

Sponsors & Collaborators

  • Applied Spectral Imaging Ltd.

    lead INDUSTRY

Principal Investigators

  • Sheila - Dobin, Ph.D. · Section Chief, Cytogenetics

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01264744 on ClinicalTrials.gov